Controlled trial of oral contraceptives in haemophilia.
D000293:Adolescent; D001779:Blood Coagulation Factors / Q000378:metabolism; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005340:Fibrinogen / Q000378:metabolism; D006177:Gynecomastia / Q000139:chemically induced; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D002836:Hemophilia B / Q000097:blood / Q000188:drug therapy*; D006470:Hemorrhage; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008656:Mestranol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D013268:Stimulation, Chemical
D001779:Blood Coagulation Factors; D004338:Drug Combinations; D010919:Placebos; D005340:Fibrinogen; D008656:Mestranol; D008234:Lynestrenol